{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:47:23Z","timestamp":1781246843715,"version":"3.54.1"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12265-021-10115-x","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T17:03:20Z","timestamp":1615482200000},"page":"1117-1124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["TMA\/TMAO in Hypertension: Novel Horizons and Potential Therapies"],"prefix":"10.1007","volume":"14","author":[{"given":"Wan-Qin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Jiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Jia","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Jin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4073-9083","authenticated-orcid":false,"given":"Shi-Chao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"10115_CR1","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/S0140-6736(16)31679-8","volume":"388","author":"GBD","year":"2015","unstructured":"GBD. (2015). Risk Factors Collaborators (2016) Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388, 1659\u20131724. https:\/\/doi.org\/10.1016\/S0140-6736(16)31679-8.","journal-title":"Lancet"},{"key":"10115_CR2","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(08)60655-8","volume":"371","author":"CM Lawes","year":"2008","unstructured":"Lawes, C. M., Vander Hoorn, S., & Rodgers, A. (2008). International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet, 371, 1513\u20131518. https:\/\/doi.org\/10.1016\/S0140-6736(08)60655-8.","journal-title":"Lancet"},{"key":"10115_CR3","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1161\/HYP.0000000000000065","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton, P. K., Carey, R. M., & Aronow, W. S. (2018). 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension, 71, e13\u2013e115. https:\/\/doi.org\/10.1161\/HYP.0000000000000065.","journal-title":"Hypertension"},{"key":"10115_CR4","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1161\/CIR.0000000000000366","volume":"133","author":"D Mozaffarian","year":"2016","unstructured":"Writing Group Members, Mozaffarian, D., Benjamin, E. J., & Go, A. S. (2016). Stroke Statistics Subcommittee. Executive Summary: Heart Disease and Stroke Statistics\u20142016 Update: A report from the American Heart Association. Circulation, 133, 447\u2013454. https:\/\/doi.org\/10.1161\/CIR.0000000000000366.","journal-title":"Circulation"},{"key":"10115_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1084\/jem.20171773","volume":"215","author":"AE Norlander","year":"2018","unstructured":"Norlander, A. E., Madhur, M. S., & Harrison, D. G. (2018). The immunology of hypertension. The Journal of Experimental Medicine, 215, 21\u201333. https:\/\/doi.org\/10.1084\/jem.20171773.","journal-title":"The Journal of Experimental Medicine"},{"key":"10115_CR6","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nri3523","volume":"13","author":"C Kurts","year":"2013","unstructured":"Kurts, C., Panzer, U., Anders, H. J., et al. (2013). The immune system and kidney disease: Basic concepts and clinical implications. Nature Reviews. Immunology, 13, 738\u2013753. https:\/\/doi.org\/10.1038\/nri3523.","journal-title":"Nature Reviews. Immunology"},{"key":"10115_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1161\/CIRCRESAHA.119.313965","volume":"125","author":"J Zubcevic","year":"2019","unstructured":"Zubcevic, J., Richards, E. M., Yang, T., et al. (2019). Impaired autonomic nervous system-microbiome circuit in hypertension. Circulation Research, 125, 104\u2013116. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.313965.","journal-title":"Circulation Research"},{"key":"10115_CR8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.lfs.2018.10.028","volume":"213","author":"HN Zhang","year":"2018","unstructured":"Zhang, H. N., Xu, Q. Q., Thakur, A., et al. (2018). Endothelial dysfunction in diabetes and hypertension: Role of microRNAs and long non-coding RNAs. Life Sciences, 213, 258\u2013268. https:\/\/doi.org\/10.1016\/j.lfs.2018.10.028.","journal-title":"Life Sciences"},{"key":"10115_CR9","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.3390\/molecules24213992","volume":"24","author":"A Amedei","year":"2019","unstructured":"Amedei, A., & Morbidelli, L. (2019). Circulating metabolites originating from gut microbiota control endothelial cell function. Molecules, 24, 3992. https:\/\/doi.org\/10.3390\/molecules24213992.","journal-title":"Molecules"},{"key":"10115_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12929-019-0554-5","volume":"26","author":"CS Chang","year":"2019","unstructured":"Chang, C. S., & Kao, C. Y. (2019). Current understanding of the gut microbiota shaping mechanisms. Journal of Biomedical Science, 26, 59. https:\/\/doi.org\/10.1186\/s12929-019-0554-5.","journal-title":"Journal of Biomedical Science"},{"key":"10115_CR11","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","volume":"120","author":"WH Tang","year":"2017","unstructured":"Tang, W. H., Kitai, T., & Hazen, S. L. (2017). Gut microbiota in cardiovascular health and disease. Circulation Research, 120, 1183\u20131196. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.309715.","journal-title":"Circulation Research"},{"key":"10115_CR12","doi-asserted-by":"publisher","unstructured":"Gambardella, J., Castellanos, V., & Santulli, G. (2020). Standardizing translational microbiome studies and metagenomic analyses. Cardiovascular Research, cvaa175. https:\/\/doi.org\/10.1093\/cvr\/cvaa175.","DOI":"10.1093\/cvr\/cvaa175"},{"key":"10115_CR13","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","volume":"8","author":"Z Jie","year":"2017","unstructured":"Jie, Z., Xia, H., Zhong, S. L., et al. (2017). The gut microbiome in atherosclerotic cardiovascular disease. Nature Communications, 8, 845. https:\/\/doi.org\/10.1038\/s41467-017-00900-1.","journal-title":"Nature Communications"},{"key":"10115_CR14","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/eurheartj\/ehw582","volume":"38","author":"XS Li","year":"2017","unstructured":"Li, X. S., Obeid, S., Klingenberg, R., et al. (2017). Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: A prognostic marker for incident cardiovascular events beyond traditional risk factors. European Heart Journal, 38, 814\u2013824. https:\/\/doi.org\/10.1093\/eurheartj\/ehw582.","journal-title":"European Heart Journal"},{"key":"10115_CR15","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1042\/BCJ20160510","volume":"474","author":"E Thursby","year":"2017","unstructured":"Thursby, E., & Juge, N. (2017). Introduction to the human gut microbiota. The Biochemical Journal, 474, 1823\u20131836. https:\/\/doi.org\/10.1042\/BCJ20160510.","journal-title":"The Biochemical Journal"},{"key":"10115_CR16","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1038\/cti.2017.6","volume":"6","author":"SD Shukla","year":"2017","unstructured":"Shukla, S. D., Budden, K. F., Neal, R., et al. (2017). Microbiome effects on immunity, health and disease in the lung. Clinical & Translational Immunology, 6, e133. https:\/\/doi.org\/10.1038\/cti.2017.6.","journal-title":"Clinical & Translational Immunology"},{"key":"10115_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","volume":"464","author":"J Qin","year":"2010","unstructured":"Qin, J., Li, R., Raes, J., et al. (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature, 464, 59\u201365. https:\/\/doi.org\/10.1038\/nature08821.","journal-title":"Nature"},{"key":"10115_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/nature09944","volume":"473","author":"M Arumugam","year":"2011","unstructured":"Arumugam, M., Raes, J., Pelletier, E., et al. (2011). Enterotypes of the human gut microbiome. Nature, 473, 174\u2013180. https:\/\/doi.org\/10.1038\/nature09944.","journal-title":"Nature"},{"key":"10115_CR19","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.3390\/nu11102393","volume":"11","author":"E Rinninella","year":"2019","unstructured":"Rinninella, E., Cintoni, M., Raoul, P., et al. (2019). Food components and dietary habits: Keys for a healthy gut microbiota composition. Nutrients, 11, 2393. https:\/\/doi.org\/10.3390\/nu11102393.","journal-title":"Nutrients"},{"key":"10115_CR20","doi-asserted-by":"publisher","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","volume":"21","author":"SM Jandhyala","year":"2015","unstructured":"Jandhyala, S. M., Talukdar, R., Subramanyam, C., et al. (2015). Role of the normal gut microbiota. World Journal of Gastroenterology, 21, 8787\u20138803. https:\/\/doi.org\/10.3748\/wjg.v21.i29.8787.","journal-title":"World Journal of Gastroenterology"},{"key":"10115_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-nutr-071816-064732","volume":"37","author":"SH Zeisel","year":"2017","unstructured":"Zeisel, S. H., & Warrier, M. (2017). Trimethylamine N-oxide, the microbiome, and heart and kidney disease. Annual Review of Nutrition, 37, 157\u2013181. https:\/\/doi.org\/10.1146\/annurev-nutr-071816-064732.","journal-title":"Annual Review of Nutrition"},{"key":"10115_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.tem.2016.10.005","volume":"28","author":"CE Cho","year":"2017","unstructured":"Cho, C. E., & Caudill, M. A. (2017). Trimethylamine-N-oxide: Friend, foe, or simply caught in the cross-fire? Trends in Endocrinology and Metabolism: TEM, 28, 121\u2013130. https:\/\/doi.org\/10.1016\/j.tem.2016.10.005.","journal-title":"Trends in Endocrinology and Metabolism: TEM"},{"key":"10115_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13293-019-0240-z","volume":"10","author":"AC Razavi","year":"2019","unstructured":"Razavi, A. C., Potts, K. S., Kelly, T. N., et al. (2019). Sex, gut microbiome, and cardiovascular disease risk. Biology of Sex Differences, 10, 29. https:\/\/doi.org\/10.1186\/s13293-019-0240-z.","journal-title":"Biology of Sex Differences"},{"key":"10115_CR24","doi-asserted-by":"publisher","first-page":"6458094","DOI":"10.1155\/2018\/6458094","volume":"2018","author":"J Bu","year":"2018","unstructured":"Bu, J., & Wang, Z. (2018). Cross-talk between gut microbiota and heart via the routes of metabolite and immunity. Gastroenterology Research and Practice, 2018, 6458094. https:\/\/doi.org\/10.1155\/2018\/6458094.","journal-title":"Gastroenterology Research and Practice"},{"key":"10115_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40168-018-0461-0","volume":"6","author":"L Hoyles","year":"2018","unstructured":"Hoyles, L., Jim\u00e9nez-Pranteda, M. L., Chilloux, J., et al. (2018). Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota. Microbiome, 6, 73. https:\/\/doi.org\/10.1186\/s40168-018-0461-0.","journal-title":"Microbiome"},{"key":"10115_CR26","doi-asserted-by":"publisher","first-page":"e0189310","DOI":"10.1371\/journal.pone.0189310","volume":"12","author":"K Jaworska","year":"2017","unstructured":"Jaworska, K., Huc, T., Samborowska, E., et al. (2017). Hypertension in rats is associated with an increased permeability of the colon to TMA, a gut bacteria metabolite. PLoS One, 12, e0189310. https:\/\/doi.org\/10.1371\/journal.pone.0189310.","journal-title":"PLoS One"},{"key":"10115_CR27","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1124\/dmd.116.070615","volume":"44","author":"D Fennema","year":"2016","unstructured":"Fennema, D., Phillips, I. R., & Shephard, E. A. (2016). Trimethylamine and trimethylamine N-oxide, a flavin-containing monooxygenase 3 (FMO3)-mediated host-microbiome metabolic axis implicated in health and disease. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 44, 1839\u20131850. https:\/\/doi.org\/10.1124\/dmd.116.070615.","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10115_CR28","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/bph.13959","volume":"175","author":"S Subramaniam","year":"2018","unstructured":"Subramaniam, S., & Fletcher, C. (2018). Trimethylamine N-oxide: Breathe new life. British Journal of Pharmacology, 175, 1344\u20131353. https:\/\/doi.org\/10.1111\/bph.13959.","journal-title":"British Journal of Pharmacology"},{"key":"10115_CR29","doi-asserted-by":"publisher","first-page":"e000080","DOI":"10.1099\/mgen.0.000080","volume":"2","author":"E Jameson","year":"2016","unstructured":"Jameson, E., Doxey, A. C., Airs, R., et al. (2016). Metagenomic data-mining reveals contrasting microbial populations responsible for trimethylamine formation in human gut and marine ecosystems. Microbial Genomics, 2, e000080. https:\/\/doi.org\/10.1099\/mgen.0.000080.","journal-title":"Microbial Genomics"},{"key":"10115_CR30","doi-asserted-by":"publisher","first-page":"6471","DOI":"10.1021\/acs.jpcb.8b02159","volume":"122","author":"QD Pham","year":"2018","unstructured":"Pham, Q. D., Wolde-Kidan, A., Gupta, A., et al. (2018). Effects of urea and TMAO on lipid self-assembly under osmotic stress conditions. The Journal of Physical Chemistry. B, 122, 6471\u20136482. https:\/\/doi.org\/10.1021\/acs.jpcb.8b02159.","journal-title":"The Journal of Physical Chemistry. B"},{"key":"10115_CR31","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1073\/pnas.1614609114","volume":"114","author":"YT Liao","year":"2017","unstructured":"Liao, Y. T., Manson, A. C., DeLyser, M. R., et al. (2017). Trimethylamine N-oxide stabilizes proteins via a distinct mechanism compared with betaine and glycine. Proceedings of the National Academy of Sciences of the United States of America, 114, 2479\u20132484. https:\/\/doi.org\/10.1073\/pnas.1614609114.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10115_CR32","doi-asserted-by":"publisher","first-page":"100","DOI":"10.14744\/AnatolJCardiol.2019.03292","volume":"22","author":"G Mancia","year":"2019","unstructured":"Mancia, G. (2019). Initial combination treatment in the 2018 ESC\/ESH hypertension guidelines. Anatolian Journal of Cardiology, 22, 100\u2013101. https:\/\/doi.org\/10.14744\/AnatolJCardiol.2019.03292.","journal-title":"Anatolian Journal of Cardiology"},{"key":"10115_CR33","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1161\/HYPERTENSIONAHA.115.05315","volume":"65","author":"T Yang","year":"2015","unstructured":"Yang, T., Santisteban, M. M., Rodriguez, V., et al. (2015). Gut dysbiosis is linked to hypertension. Hypertension, 65, 1331\u20131340. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.05315.","journal-title":"Hypertension"},{"key":"10115_CR34","doi-asserted-by":"publisher","first-page":"e1900073","DOI":"10.1002\/mnfr.201900073","volume":"63","author":"CN Hsu","year":"2019","unstructured":"Hsu, C. N., Chang-Chien, G. P., Lin, S., et al. (2019). Targeting on gut microbial metabolite trimethylamine-N-oxide and short-chain fatty acid to prevent maternal high-fructose-diet-induced developmental programming of hypertension in adult male offspring. Molecular Nutrition & Food Research, 63, e1900073. https:\/\/doi.org\/10.1002\/mnfr.201900073.","journal-title":"Molecular Nutrition & Food Research"},{"key":"10115_CR35","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41581-018-0018-2","volume":"14","author":"T Yang","year":"2018","unstructured":"Yang, T., Richards, E. M., Pepine, C. J., et al. (2018). The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease. Nature Reviews. Nephrology, 14, 442\u2013456. https:\/\/doi.org\/10.1038\/s41581-018-0018-2.","journal-title":"Nature Reviews. Nephrology"},{"key":"10115_CR36","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/jcm9020336","volume":"9","author":"CN Hsu","year":"2020","unstructured":"Hsu, C. N., Chang-Chien, G. P., Lin, S., et al. (2020). Association of trimethylamine, trimethylamine N-oxide, and dimethylamine with cardiovascular risk in children with chronic kidney disease. Journal of Clinical Medicine, 9, 336. https:\/\/doi.org\/10.3390\/jcm9020336.","journal-title":"Journal of Clinical Medicine"},{"key":"10115_CR37","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1042\/CS20180087","volume":"132","author":"S Kim","year":"2018","unstructured":"Kim, S., Goel, R., Kumar, A., et al. (2018). Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. Clinical Science, 132, 701\u2013718. https:\/\/doi.org\/10.1042\/CS20180087.","journal-title":"Clinical Science"},{"key":"10115_CR38","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3389\/fcimb.2017.00381","volume":"7","author":"Q Yan","year":"2017","unstructured":"Yan, Q., Gu, Y., Li, X., et al. (2017). Alterations of the gut microbiome in hypertension. Frontiers in Cellular and Infection Microbiology, 7, 381. https:\/\/doi.org\/10.3389\/fcimb.2017.00381.","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"10115_CR39","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.3390\/jcm8081090","volume":"8","author":"CN Hsu","year":"2019","unstructured":"Hsu, C. N., Lu, P. C., Hou, C. Y., et al. (2019). Blood pressure abnormalities associated with gut microbiota-derived short chain fatty acids in children with congenital anomalies of the kidney and urinary tract. Journal of Clinical Medicine, 8, 1090. https:\/\/doi.org\/10.3390\/jcm8081090.","journal-title":"Journal of Clinical Medicine"},{"key":"10115_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40168-016-0222-x","volume":"5","author":"J Li","year":"2017","unstructured":"Li, J., Zhao, F., Wang, Y., et al. (2017). Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome, 5, 14. https:\/\/doi.org\/10.1186\/s40168-016-0222-x.","journal-title":"Microbiome"},{"key":"10115_CR41","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3390\/jcm8081110","volume":"8","author":"MM Grant","year":"2019","unstructured":"Grant, M. M., & J\u00f6nsson, D. (2019). Next generation sequencing discoveries of the nitrate-responsive oral microbiome and its effect on vascular responses. Journal of Clinical Medicine, 8, 1110. https:\/\/doi.org\/10.3390\/jcm8081110.","journal-title":"Journal of Clinical Medicine"},{"key":"10115_CR42","doi-asserted-by":"publisher","first-page":"20212028","DOI":"10.1161\/STROKEAHA.118.021997","volume":"49","author":"J Nie","year":"2018","unstructured":"Nie, J., Xie, L., Zhao, B., et al. (2018). Serum trimethylamine N-oxide concentration is positively associated with first stroke in hypertensive patients. Stroke, 49, 20212028. https:\/\/doi.org\/10.1161\/STROKEAHA.118.021997.","journal-title":"Stroke"},{"key":"10115_CR43","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/advances\/nmz064","volume":"11","author":"X Ge","year":"2020","unstructured":"Ge, X., Zheng, L., Zhuang, R., et al. (2020). The gut microbial metabolite trimethylamine N-oxide and hypertension risk: A systematic review and dose-response meta-analysis. Advances in Nutrition, 11, 66\u201376. https:\/\/doi.org\/10.1093\/advances\/nmz064.","journal-title":"Advances in Nutrition"},{"key":"10115_CR44","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","volume":"163","author":"Z Wang","year":"2015","unstructured":"Wang, Z., Roberts, A. B., Buffa, J. A., et al. (2015). Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell, 163, 1585\u20131595. https:\/\/doi.org\/10.1016\/j.cell.2015.11.055.","journal-title":"Cell"},{"key":"10115_CR45","doi-asserted-by":"publisher","first-page":"e13443","DOI":"10.14814\/phy2.13443","volume":"5","author":"J Rowin","year":"2017","unstructured":"Rowin, J., Xia, Y., Jung, B., et al. (2017). Gut inflammation and dysbiosis in human motor neuron disease. Physiological Reports, 5, e13443. https:\/\/doi.org\/10.14814\/phy2.13443.","journal-title":"Physiological Reports"},{"key":"10115_CR46","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1152\/physiolgenomics.00081.2016","volume":"49","author":"S Adnan","year":"2017","unstructured":"Adnan, S., Nelson, J. W., Ajami, N. J., et al. (2017). Alterations in the gut microbiota can elicit hypertension in rats. Physiological Genomics, 49, 96\u2013104. https:\/\/doi.org\/10.1152\/physiolgenomics.00081.2016.","journal-title":"Physiological Genomics"},{"key":"10115_CR47","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cjca.2014.09.010","volume":"30","author":"M Ufnal","year":"2014","unstructured":"Ufnal, M., Jazwiec, R., Dadlez, M., et al. (2014). Trimethylamine-N-oxide: A carnitine-derived metabolite that prolongs the hypertensive effect of angiotensin II in rats. The Canadian Journal of Cardiology, 30, 1700\u20131705. https:\/\/doi.org\/10.1016\/j.cjca.2014.09.010.","journal-title":"The Canadian Journal of Cardiology"},{"key":"10115_CR48","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cjca.2017.12.005","volume":"34","author":"JR Petrie","year":"2018","unstructured":"Petrie, J. R., Guzik, T. J., & Touyz, R. M. (2018). Diabetes, hypertension, and cardiovascular disease: Clinical insights and vascular mechanisms. The Canadian Journal of Cardiology, 34, 575\u2013584. https:\/\/doi.org\/10.1016\/j.cjca.2017.12.005.","journal-title":"The Canadian Journal of Cardiology"},{"key":"10115_CR49","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1152\/physrev.00031.2016","volume":"97","author":"B Rodriguez-Iturbe","year":"2017","unstructured":"Rodriguez-Iturbe, B., Pons, H., & Johnson, R. J. (2017). Role of the immune system in hypertension. Physiological Reviews, 97, 1127\u20131164. https:\/\/doi.org\/10.1152\/physrev.00031.2016.","journal-title":"Physiological Reviews"},{"key":"10115_CR50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.arr.2016.01.007","volume":"26","author":"TW Buford","year":"2016","unstructured":"Buford, T. W. (2016). Hypertension and aging. Ageing Research Reviews, 26, 96\u2013111. https:\/\/doi.org\/10.1016\/j.arr.2016.01.007.","journal-title":"Ageing Research Reviews"},{"key":"10115_CR51","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3390\/biomedicines8080287","volume":"8","author":"E Sanchez-Morate","year":"2020","unstructured":"Sanchez-Morate, E., Gimeno-Mallench, L., Stromsnes, K., et al. (2020). Relationship between diet, microbiota, and healthy aging. Biomedicines, 8, 287. https:\/\/doi.org\/10.3390\/biomedicines8080287.","journal-title":"Biomedicines"},{"key":"10115_CR52","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/biomedicines8010008","volume":"8","author":"AK Sikalidis","year":"2020","unstructured":"Sikalidis, A. K., & Maykish, A. (2020). The gut microbiome and type 2 diabetes mellitus: Discussing a complex relationship. Biomedicines, 8, 8. https:\/\/doi.org\/10.3390\/biomedicines8010008.","journal-title":"Biomedicines"},{"key":"10115_CR53","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11906-019-0964-5","volume":"21","author":"M Tanaka","year":"2019","unstructured":"Tanaka, M., & Itoh, H. (2019). Hypertension as a metabolic disorder and the novel role of the gut. Current Hypertension Reports, 21, 63. https:\/\/doi.org\/10.1007\/s11906-019-0964-5.","journal-title":"Current Hypertension Reports"},{"key":"10115_CR54","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12944-018-0939-6","volume":"17","author":"L Ding","year":"2018","unstructured":"Ding, L., Chang, M., Guo, Y., et al. (2018). Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism. Lipids in Health and Disease, 17, 286. https:\/\/doi.org\/10.1186\/s12944-018-0939-6.","journal-title":"Lipids in Health and Disease"},{"key":"10115_CR55","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth, R. A., Wang, Z., Levison, B. S., et al. (2013). Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nature Medicine, 19, 576\u2013585. https:\/\/doi.org\/10.1038\/nm.3145.","journal-title":"Nature Medicine"},{"key":"10115_CR56","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.3390\/ijms19103228","volume":"19","author":"M Canyelles","year":"2018","unstructured":"Canyelles, M., Tondo, M., Ced\u00f3, L., et al. (2018). Trimethylamine N-oxide: A link among diet, gut microbiota, gene regulation of liver and intestine cholesterol homeostasis and HDL function. International Journal of Molecular Sciences, 19, 3228. https:\/\/doi.org\/10.3390\/ijms19103228.","journal-title":"International Journal of Molecular Sciences"},{"key":"10115_CR57","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3390\/nu10101398","volume":"10","author":"MH Janeiro","year":"2018","unstructured":"Janeiro, M. H., Ram\u00edrez, M. J., Milagro, F. I., et al. (2018). Implication of trimethylamine N-oxide (TMAO) in disease: Potential biomarker or new therapeutic target. Nutrients, 10, 1398. https:\/\/doi.org\/10.3390\/nu10101398.","journal-title":"Nutrients"},{"key":"10115_CR58","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3389\/fphar.2018.01082","volume":"9","author":"J Ma","year":"2018","unstructured":"Ma, J., & Li, H. (2018). The role of gut microbiota in atherosclerosis and hypertension. Frontiers in Pharmacology, 9, 1082. https:\/\/doi.org\/10.3389\/fphar.2018.01082.","journal-title":"Frontiers in Pharmacology"},{"key":"10115_CR59","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.3390\/jcm8111813","volume":"8","author":"E Garcia","year":"2019","unstructured":"Garcia, E., Ost\u00e9, M., Bennett, D. W., et al. (2019). High betaine, a trimethylamine N-oxide related metabolite, is prospectively associated with low future risk of type 2 diabetes mellitus in the PREVEND study. Journal of Clinical Medicine, 8, 1813. https:\/\/doi.org\/10.3390\/jcm8111813.","journal-title":"Journal of Clinical Medicine"},{"key":"10115_CR60","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1055\/s-0035-1569330","volume":"124","author":"M Dambrova","year":"2016","unstructured":"Dambrova, M., Latkovskis, G., Kuka, J., et al. (2016). Diabetes is associated with higher trimethylamine N-oxide plasma levels. Experimental and Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association, 124, 251\u2013256. https:\/\/doi.org\/10.1055\/s-0035-1569330.","journal-title":"Experimental and Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association"},{"key":"10115_CR61","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1016\/j.celrep.2017.05.077","volume":"19","author":"RC Schugar","year":"2017","unstructured":"Schugar, R. C., Shih, D. M., Warrier, M., et al. (2017). The TMAO-producing enzyme flavin-containing monooxygenase 3 regulates obesity and the beiging of white adipose tissue. Cell Reports, 19, 2451\u20132461. https:\/\/doi.org\/10.1016\/j.celrep.2017.05.077.","journal-title":"Cell Reports"},{"key":"10115_CR62","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.3390\/nu10121971","volume":"10","author":"L Barrea","year":"2018","unstructured":"Barrea, L., Annunziata, G., Muscogiuri, G., et al. (2018). Trimethylamine-N-oxide (TMAO) as novel potential biomarker of early predictors of metabolic syndrome. Nutrients, 10, 1971. https:\/\/doi.org\/10.3390\/nu10121971.","journal-title":"Nutrients"},{"key":"10115_CR63","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3389\/fphar.2019.00575","volume":"10","author":"G Annunziata","year":"2019","unstructured":"Annunziata, G., Maisto, M., Schisano, C., et al. (2019). Effect of grape pomace polyphenols with or without pectin on TMAO serum levels assessed by LC\/MS-based assay: a preliminary clinical study on overweight\/obese subjects. Frontiers in Pharmacology, 10, 575. https:\/\/doi.org\/10.3389\/fphar.2019.00575.","journal-title":"Frontiers in Pharmacology"},{"key":"10115_CR64","doi-asserted-by":"publisher","first-page":"6498","DOI":"10.1038\/ncomms7498","volume":"6","author":"J Miao","year":"2015","unstructured":"Miao, J., Ling, A. V., Manthena, P. V., et al. (2015). Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis. Nature Communications, 6, 6498. https:\/\/doi.org\/10.1038\/ncomms7498.","journal-title":"Nature Communications"},{"key":"10115_CR65","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1021\/acs.jpclett.6b00613","volume":"7","author":"JA Mondal","year":"2016","unstructured":"Mondal, J. A. (2016). Effect of trimethylamine N-oxide on interfacial electrostatics at phospholipid monolayer-water interfaces and its relevance to cardiovascular disease. The Journal of Physical Chemistry Letters, 7, 1704\u20131708. https:\/\/doi.org\/10.1021\/acs.jpclett.6b00613.","journal-title":"The Journal of Physical Chemistry Letters"},{"key":"10115_CR66","doi-asserted-by":"publisher","first-page":"e002767","DOI":"10.1161\/JAHA.115.002767","volume":"5","author":"MM Seldin","year":"2016","unstructured":"Seldin, M. M., Meng, Y., Qi, H., et al. (2016). Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-\u03baB. Journal of the American Heart Association, 5, e002767. https:\/\/doi.org\/10.1161\/JAHA.115.002767.","journal-title":"Journal of the American Heart Association"},{"key":"10115_CR67","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.3390\/nu11081821","volume":"11","author":"MM Chan","year":"2019","unstructured":"Chan, M. M., Yang, X., Wang, H., et al. (2019). The microbial metabolite trimethylamine N-oxide links vascular dysfunctions and the autoimmune disease rheumatoid arthritis. Nutrients, 11, 1821. https:\/\/doi.org\/10.3390\/nu11081821.","journal-title":"Nutrients"},{"key":"10115_CR68","doi-asserted-by":"publisher","first-page":"4634172","DOI":"10.1155\/2020\/4634172","volume":"2020","author":"Y Liu","year":"2020","unstructured":"Liu, Y., & Dai, M. (2020). Trimethylamine N-oxide generated by the gut microbiota is associated with vascular inflammation: New insights into atherosclerosis. Mediators of Inflammation, 2020, 4634172. https:\/\/doi.org\/10.1155\/2020\/4634172.","journal-title":"Mediators of Inflammation"},{"key":"10115_CR69","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000484623","volume":"44","author":"KM Boini","year":"2017","unstructured":"Boini, K. M., Hussain, T., Li, P. L., et al. (2017). Trimethylamine-N-oxide instigates NLRP3 inflammasome activation and endothelial dysfunction. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 44, 152\u2013162. https:\/\/doi.org\/10.1159\/000484623.","journal-title":"Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology"},{"key":"10115_CR70","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3389\/fphys.2017.00139","volume":"8","author":"K Chen","year":"2017","unstructured":"Chen, K., Zheng, X., Feng, M., et al. (2017). Gut microbiota-dependent metabolite trimethylamine N-oxide contributes to cardiac dysfunction in western diet-induced obese mice. Frontiers in Physiology, 8, 139. https:\/\/doi.org\/10.3389\/fphys.2017.00139.","journal-title":"Frontiers in Physiology"},{"key":"10115_CR71","doi-asserted-by":"publisher","first-page":"e006347","DOI":"10.1161\/JAHA.117.006347","volume":"6","author":"ML Chen","year":"2017","unstructured":"Chen, M. L., Zhu, X. H., Ran, L., et al. (2017). Trimethylamine-N-oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway. Journal of the American Heart Association, 6, e006347. https:\/\/doi.org\/10.1161\/JAHA.117.006347.","journal-title":"Journal of the American Heart Association"},{"key":"10115_CR72","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/cmi.2015.95","volume":"13","author":"EK Jo","year":"2016","unstructured":"Jo, E. K., Kim, J. K., Shin, D. M., et al. (2016). Molecular mechanisms regulating NLRP3 inflammasome activation. Cellular & Molecular Immunology, 13, 148\u2013159. https:\/\/doi.org\/10.1038\/cmi.2015.95.","journal-title":"Cellular & Molecular Immunology"},{"key":"10115_CR73","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bbrc.2016.11.017","volume":"481","author":"X Sun","year":"2016","unstructured":"Sun, X., Jiao, X., Ma, Y., et al. (2016). Trimethylamine N-oxide induces inflammation and endothelial dysfunction in human umbilical vein endothelial cells via activating ROS-TXNIP-NLRP3 inflammasome. Biochemical and Biophysical Research Communications, 481, 63\u201370. https:\/\/doi.org\/10.1016\/j.bbrc.2016.11.017.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10115_CR74","doi-asserted-by":"publisher","first-page":"BSR20160244","DOI":"10.1042\/BSR20160244","volume":"37","author":"G Ma","year":"2017","unstructured":"Ma, G., Pan, B., Chen, Y., et al. (2017). Trimethylamine N-oxide in atherogenesis: Impairing endothelial self-repair capacity and enhancing monocyte adhesion. Bioscience Reports, 37, BSR20160244. https:\/\/doi.org\/10.1042\/BSR20160244.","journal-title":"Bioscience Reports"},{"key":"10115_CR75","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","volume":"165","author":"W Zhu","year":"2016","unstructured":"Zhu, W., Gregory, J. C., Org, E., et al. (2016). Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell, 165, 111\u2013124. https:\/\/doi.org\/10.1016\/j.cell.2016.02.011.","journal-title":"Cell"},{"key":"10115_CR76","doi-asserted-by":"publisher","first-page":"151","DOI":"10.5853\/jos.2019.00472","volume":"21","author":"HS Nam","year":"2019","unstructured":"Nam, H. S. (2019). Gut microbiota and ischemic stroke: The role of trimethylamine N-oxide. Journal of Stroke, 21, 151\u2013159. https:\/\/doi.org\/10.5853\/jos.2019.00472.","journal-title":"Journal of Stroke"},{"key":"10115_CR77","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.3389\/fphar.2019.01360","volume":"10","author":"S Yang","year":"2019","unstructured":"Yang, S., Li, X., Yang, F., et al. (2019). Gut microbiota-dependent marker TMAO in promoting cardiovascular disease: Inflammation mechanism, clinical prognostic, and potential as a therapeutic target. Frontiers in Pharmacology, 10, 1360. https:\/\/doi.org\/10.3389\/fphar.2019.01360.","journal-title":"Frontiers in Pharmacology"},{"key":"10115_CR78","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1161\/ATVBAHA.117.309123","volume":"37","author":"PM Marcovecchio","year":"2017","unstructured":"Marcovecchio, P. M., Thomas, G. D., Mikulski, Z., et al. (2017). Scavenger receptor CD36 directs nonclassical monocyte patrolling along the endothelium during early atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 37, 2043\u20132052. https:\/\/doi.org\/10.1161\/ATVBAHA.117.309123.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10115_CR79","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang, Z., Klipfell, E., Bennett, B. J., et al. (2011). Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature, 472, 57\u201363. https:\/\/doi.org\/10.1038\/nature09922.","journal-title":"Nature"},{"key":"10115_CR80","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.biopha.2017.11.016","volume":"97","author":"J Geng","year":"2018","unstructured":"Geng, J., Yang, C., Wang, B., et al. (2018). Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK\/JNK pathway. Biomedicine & Pharmacotherapy, 97, 941\u2013947. https:\/\/doi.org\/10.1016\/j.biopha.2017.11.016.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10115_CR81","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3390\/toxins8110326","volume":"8","author":"MT Velasquez","year":"2016","unstructured":"Velasquez, M. T., Ramezani, A., Manal, A., et al. (2016). Trimethylamine N-oxide: The good, the bad and the unknown. Toxins, 8, 326. https:\/\/doi.org\/10.3390\/toxins8110326.","journal-title":"Toxins"},{"key":"10115_CR82","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1556\/650.2018.30787","volume":"159","author":"I Barna","year":"2018","unstructured":"Barna, I., Ny\u00fal, D., Szentes, T., et al. (2018). Review of the relation between gut microbiome, metabolic disease and hypertension. Orvosi Hetilap, 159, 346\u2013351. https:\/\/doi.org\/10.1556\/650.2018.30787.","journal-title":"Orvosi Hetilap"},{"key":"10115_CR83","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.3390\/jcm9092963","volume":"9","author":"MG Sublette","year":"2020","unstructured":"Sublette, M. G., Cross, T. L., Korcarz, C. E., et al. (2020). Effects of smoking and smoking cessation on the intestinal microbiota. Journal of Clinical Medicine, 9, 2963. https:\/\/doi.org\/10.3390\/jcm9092963.","journal-title":"Journal of Clinical Medicine"},{"key":"10115_CR84","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2174\/1573402114666180613080439","volume":"15","author":"V Katsi","year":"2019","unstructured":"Katsi, V., Didagelos, M., Skevofilax, S., et al. (2019). GUT microbiome-GUT dysbiosis-arterial hypertension: New horizons. Current Hypertension Reviews, 15, 40\u201346. https:\/\/doi.org\/10.2174\/1573402114666180613080439.","journal-title":"Current Hypertension Reviews"},{"key":"10115_CR85","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1161\/CIRCRESAHA.116.309006","volume":"120","author":"MM Santisteban","year":"2017","unstructured":"Santisteban, M. M., Qi, Y., Zubcevic, J., et al. (2017). Hypertension-linked pathophysiological alterations in the gut. Circulation Research, 120, 312\u2013323. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309006.","journal-title":"Circulation Research"},{"key":"10115_CR86","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/IBPC.S73246","volume":"9","author":"A Upadrasta","year":"2016","unstructured":"Upadrasta, A., & Madempudi, R. S. (2016). Probiotics and blood pressure: Current insights. Integrated Blood Pressure Control, 9, 33\u201342. https:\/\/doi.org\/10.2147\/IBPC.S73246.","journal-title":"Integrated Blood Pressure Control"},{"key":"10115_CR87","doi-asserted-by":"publisher","first-page":"719","DOI":"10.4161\/19490976.2014.983775","volume":"5","author":"G Ettinger","year":"2014","unstructured":"Ettinger, G., MacDonald, K., Reid, G., et al. (2014). The influence of the human microbiome and probiotics on cardiovascular health. Gut Microbes, 5, 719\u2013728. https:\/\/doi.org\/10.4161\/19490976.2014.983775.","journal-title":"Gut Microbes"},{"key":"10115_CR88","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3390\/nu10060793","volume":"10","author":"ME Baugh","year":"2018","unstructured":"Baugh, M. E., Steele, C. N., Angiletta, C. J., et al. (2018). Inulin supplementation does not reduce plasma trimethylamine N-oxide concentrations in individuals at risk for type 2 diabetes. Nutrients, 10, 793. https:\/\/doi.org\/10.3390\/nu10060793.","journal-title":"Nutrients"},{"key":"10115_CR89","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1080\/10408398.2014.883356","volume":"57","author":"R Pei","year":"2017","unstructured":"Pei, R., Martin, D. A., DiMarco, D. M., et al. (2017). Evidence for the effects of yogurt on gut health and obesity. Critical Reviews in Food Science and Nutrition, 57, 1569\u20131583. https:\/\/doi.org\/10.1080\/10408398.2014.883356.","journal-title":"Critical Reviews in Food Science and Nutrition"},{"key":"10115_CR90","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1161\/HYPERTENSIONAHA.114.03469","volume":"64","author":"S Khalesi","year":"2014","unstructured":"Khalesi, S., Sun, J., Buys, N., et al. (2014). Effect of probiotics on blood pressure: A systematic review and meta-analysis of randomized, controlled trials. Hypertension, 64, 897\u2013903. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.03469.","journal-title":"Hypertension"},{"key":"10115_CR91","doi-asserted-by":"publisher","first-page":"14752","DOI":"10.1038\/s41598-018-33018-5","volume":"8","author":"A Ramezani","year":"2018","unstructured":"Ramezani, A., Nolin, T. D., Barrows, I. R., et al. (2018). Gut colonization with methanogenic archaea lowers plasma trimethylamine N-oxide concentrations in apolipoprotein e-\/- mice. Scientific Reports, 8, 14752. https:\/\/doi.org\/10.1038\/s41598-018-33018-5.","journal-title":"Scientific Reports"},{"key":"10115_CR92","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1113\/JP277336","volume":"597","author":"VE Brunt","year":"2019","unstructured":"Brunt, V. E., Gioscia-Ryan, R. A., Richey, J. J., et al. (2019). Suppression of the gut microbiome ameliorates age-related arterial dysfunction and oxidative stress in mice. The Journal of Physiology, 597, 2361\u20132378. https:\/\/doi.org\/10.1113\/JP277336.","journal-title":"The Journal of Physiology"},{"key":"10115_CR93","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1152\/physiolgenomics.00073.2018","volume":"50","author":"S Galla","year":"2018","unstructured":"Galla, S., Chakraborty, S., Cheng, X., et al. (2018). Disparate effects of antibiotics on hypertension. Physiological Genomics, 50, 837\u2013884. https:\/\/doi.org\/10.1152\/physiolgenomics.00073.2018.","journal-title":"Physiological Genomics"},{"key":"10115_CR94","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s13238-018-0541-8","volume":"9","author":"F Zhang","year":"2018","unstructured":"Zhang, F., Cui, B., He, X., et al. (2018). Microbiota transplantation: Concept, methodology and strategy for its modernization. Protein & Cell, 9, 462\u2013473. https:\/\/doi.org\/10.1007\/s13238-018-0541-8.","journal-title":"Protein & Cell"},{"key":"10115_CR95","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.phrs.2018.11.042","volume":"139","author":"XF Hu","year":"2019","unstructured":"Hu, X. F., Zhang, W. Y., Wen, Q., et al. (2019). Fecal microbiota transplantation alleviates myocardial damage in myocarditis by restoring the microbiota composition. Pharmacological Research, 139, 412\u2013421. https:\/\/doi.org\/10.1016\/j.phrs.2018.11.042.","journal-title":"Pharmacological Research"},{"key":"10115_CR96","doi-asserted-by":"publisher","first-page":"e02210","DOI":"10.1128\/mBio.02210-15","volume":"7","author":"ML Chen","year":"2016","unstructured":"Chen, M. L., Yi, L., Zhang, Y., et al. (2016). Resveratrol attenuates trimethylamine-N-oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota. mBio, 7, e02210\u2013ee2215. https:\/\/doi.org\/10.1128\/mBio.02210-15.","journal-title":"mBio"},{"key":"10115_CR97","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1080\/1354750X.2018.1432689","volume":"23","author":"M Konop","year":"2018","unstructured":"Konop, M., Radkowski, M., Grochowska, M., et al. (2018). Enalapril decreases rat plasma concentration of TMAO, a gut bacteria-derived cardiovascular marker. Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals, 23, 380\u2013385. https:\/\/doi.org\/10.1080\/1354750X.2018.1432689.","journal-title":"Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-021-10115-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-021-10115-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-021-10115-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T04:40:39Z","timestamp":1638938439000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-021-10115-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":97,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10115"],"URL":"https:\/\/doi.org\/10.1007\/s12265-021-10115-x","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,11]]},"assertion":[{"value":"6 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}